Skip to main content
Current clinical trials for craniopharyngiomas: what's on the horizon?
Relationship between 7T MR-angiography features of vascular injury and cognitive decline in young brain tumor patients treated with radiation therapy.
Diffuse midline glioma: review of epigenetics.
A systematic review and meta-analysis of outcomes in pediatric, recurrent ependymoma.
Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201.
Reirradiation and PD-1 inhibition with nivolumab for the treatment of recurrent diffuse intrinsic pontine glioma: a single-institution experience.
Survival outcomes in pediatric recurrent high-grade glioma: results of a 20-year systematic review and meta-analysis.
New therapeutic approaches for brainstem tumors: a comparison of delivery routes using nanoliposomal irinotecan in an animal model.
Pediatric high-grade glioma: current molecular landscape and therapeutic approaches.
Combined BRAFV600E and MEK blockade for BRAFV600E-mutant gliomas.